PCI Biotech Holding ASA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PCI Biotech Holding ASA with three other
miscellaneous service companies in Europe:
sales of 4.63 million Polish New Zlotys [US$1.23 million]
Kuros Biosciences AG
(1.06 million Swiss Francs [US$1.09 million]
Faron Pharmaceuticals Oy
based in the United Kingdom
(£946,543.82 [US$1.23 million]
PCI Biotech Holding ASA reported sales of NOK 10.48 million (US$1.25 million)
December of 2016.
a very small
increase of 0.1%
versus 2015, when the company's sales were NOK 10.47 million.
This was the third consecutive year of growth at PCI Biotech Holding ASA.